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PREFACE
The assessment of left ventricular (LV) diastolic function should be an
integral part of a routine examination, particularly in patients present-
ing with dyspnea or heart failure. About half of patients with new
diagnoses of heart failure have normal or near normal global ejection
fractions (EFs). These patients are diagnosed with “diastolic heart
failure” or “heart failure with preserved EF.”1 The assessment of LV
diastolic function and ﬁlling pressures is of paramount clinical impor-
tance to distinguish this syndrome from other diseases such as
pulmonary disease resulting in dyspnea, to assess prognosis, and to
identify underlying cardiac disease and its best treatment.
LV ﬁlling pressures as measured invasively include mean pulmo-
nary wedge pressure or mean left atrial (LA) pressure (both in the
absence of mitral stenosis), LV end-diastolic pressure (LVEDP; the
pressure at the onset of the QRS complex or after A-wave pressure),
and pre-A LV diastolic pressure (Figure 1). Although these pressures
are different in absolute terms, they are closely related, and they
change in a predictable progression with myocardial disease, such
that LVEDP increases prior to the rise in mean LA pressure.
Echocardiography has played a central role in the evaluation of LV
diastolic function over the past two decades. The purposes of thisdocument is to provide a comprehensive review of the techniques
and the signiﬁcance of diastolic parameters, as well as recommenda-
tions for nomenclature and reporting of diastolic data in adults. The
recommendations are based on a critical review of the literature and
the consensus of a panel of experts.
I. PHYSIOLOGY
The optimal performance of the left ventricle depends on its ability to
cycle between two states: (1) a compliant chamber in diastole that
allows the left ventricle to ﬁll from low LA pressure and (2) a stiff
chamber (rapidly rising pressure) in systole that ejects the stroke
volume at arterial pressures. The ventricle has two alternating func-
tions: systolic ejection and diastolic ﬁlling. Furthermore, the stroke
volume must increase in response to demand, such as exercise,
without much increase in LA pressure.2 The theoretically optimal LV
pressure curve is rectangular, with an instantaneous rise to peak and
an instantaneous fall to low diastolic pressures, which allows for the
maximum time for LV ﬁlling. This theoretically optimal situation is
approached by the cyclic interaction of myoﬁlaments and assumes
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Figure 1 The 4 phases of diastole are marked in relation to
high-fidelity pressure recordings from the left atrium (LA) and left
ventricle (LV) in anesthetized dogs. The first pressure crossover
corresponds to the end of isovolumic relaxation and mitral valve
opening. In the first phase, left atrial pressure exceeds left ven-
tricular pressure, accelerating mitral flow. Peak mitral E roughly
corresponds to the second crossover. Thereafter, left ventricular
pressure exceeds left atrial pressure, decelerating mitral flow.
These two phases correspond to rapid filling. This is followed by
slow filling, with almost no pressure differences. During atrial
contraction, left atrial pressure again exceeds left ventricular
pressure. The solid arrow points to left ventricular minimal pres-
sure, the dotted arrow to left ventricular pre-A pressure, and the
dashed arrow to left ventricular end-diastolic pressure. The upper
panel was recorded at a normal end-diastolic pressure of 8 mm
Hg. The lower panel was recorded after volume loading and an
end-diastolic pressure of 24 mm Hg. Note the larger pressure
differences in both tracings of the lower panel, reflecting de-
creased operating compliance of the LA and LV. Atrial contraction
provokes a sharp rise in left ventricular pressure, and left atrial
pressure hardly exceeds this elevated left ventricular pressure.
(Courtesy of T. C. Gillebert and A. F. Leite-Moreira.)competent mitral and aortic valves. Diastole starts at aortic valve
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heart rates), and atrial contraction.2
Elevated ﬁlling pressures are the main physiologic consequence of
diastolic dysfunction.2 Filling pressures are considered elevated when
the mean pulmonary capillary wedge pressure (PCWP) is 12 mm
Hg or when the LVEDP is 16 mm Hg.1 Filling pressures change
minimally with exercise in healthy subjects. Exercise-induced eleva-
tion of ﬁlling pressures limits exercise capacity and can indicate
diastolic dysfunction. LV ﬁlling pressures are determined mainly by
ﬁlling and passive properties of the LV wall but may be further
modulated by incomplete myocardial relaxation and variations in
diastolic myocardial tone.
At the molecular level, the cyclic interaction of myoﬁlaments leads
to a muscular contraction and relaxation cycle. Relaxation is the
process whereby the myocardium returns after contraction to its
unstressed length and force. In normal hearts, and with normal load,
myocardial relaxation is nearly complete at minimal LV pressure.
Contraction and relaxation belong to the same molecular processes
of transient activation of the myocyte and are closely intertwined.3
Relaxation is subjected to control by load, inactivation, and asyn-
chrony.2
Increased afterload or late systolic load will delay myocardial
relaxation, especially when combined with elevated preload, thereby
contributing to elevating ﬁlling pressures.4 Myocardial inactivation
relates to the processes underlying calcium extrusion from the cytosol
and cross-bridge detachment and is affected by a number of proteins
that regulate calcium homeostasis,5 cross-bridge cycling,2 and ener-
getics.3 Minor regional variation of the timing of regional contraction
and relaxation is physiological. However, dyssynchronous relaxation
results in a deleterious interaction between early reextension in some
segments and postsystolic shortening of other segments and contrib-
utes to delayed global LV relaxation and elevated ﬁlling pressures.6
The rate of global LV myocardial relaxation is reﬂected by the
monoexponential course of LV pressure fall, assuming a good ﬁt (r
0.97) to a monoexponential pressure decay. Tau is a widely accepted
invasive measure of the rate of LV relaxation, which will be 97%
complete at a time corresponding to 3.5  after dP/dtmin. Diastolic
dysfunction is present when   48 ms.1 In addition, the rate of
relaxation may be evaluated in terms of LV dP/dtmin and indirectly
with the isovolumetric relaxation time (IVRT), or the time interval
between aortic valve closure and mitral valve opening.
LV ﬁlling is determined by the interplay between LV ﬁlling pres-
sures and ﬁlling properties. These ﬁlling properties are described with
stiffness (P/V) or inversely with compliance (V/P) and com-
monly refer to end-diastolic properties. Several factors extrinsic and
intrinsic to the left ventricle determine these end-diastolic properties.
Extrinsic factors are mainly pericardial restraint and ventricular inter-
action. Intrinsic factors include myocardial stiffness (cardiomyocytes
and extracellular matrix), myocardial tone, chamber geometry, and
wall thickness.5
Chamber stiffness describes the LV diastolic pressure-volume
relationship, with a number of measurements that can be derived.
The operating stiffness at any point is equal to the slope of a tangent
drawn to the curve at that point (P/V) and can be approximated
with only two distinct pressure-volume measurements. Diastolic
dysfunction is present when the slope is0.20 mm Hg/mL.7 On the
other hand, it is possible to characterize LV chamber stiffness over
the duration of diastole by the slope of the exponential ﬁt to the diastolic
pressure-volume relation. Such a curve ﬁt can be applied to the diastolic
LV pressure-volume relation of a single beat or to the end-diastolic
pressure-volume relation constructed by ﬁtting the lower right cornerof multiple pressure-volume loops obtained at various preloads. The
latter method has the advantage of being less dependent on ongoing
myocardial relaxation. The stiffness modulus, kc, is the slope of the
curve and can be used to quantify chamber stiffness. Normal values
do not exceed 0.015 (C. Tschöpe, personal communication).
A distinct aspect of diastolic function is related to longitudinal
function and torsion. Torrent-Guasp et al8 described how the ventri-
cles may to some extent be assimilated to a single myoﬁber band
starting at the right ventricle below the pulmonary valve and forming
a double helix extending to the left ventricle, where it attaches to the
aorta. This double helicoidal ﬁber orientation leads to systolic twisting
(torsion) and diastolic untwisting (torsional recoil).
Key Points
1. Diastolic function is related to myocardial relaxation and passive LV
properties and is modulated by myocardial tone.
2. Myocardial relaxation is determined by load, inactivation, and nonunifor-
mity.
3. Myocardial stiffness is determined by the myocardial cell (eg, titin) and by
the interstitial matrix (ﬁbrosis).
II. MORPHOLOGIC AND FUNCTIONAL CORRELATES OF
DIASTOLIC DYSFUNCTION
A. LV Hypertrophy
Although diastolic dysfunction is not uncommon in patients with
normal wall thickness, LV hypertrophy is among the important
reasons for it. In patients with diastolic heart failure, concentric
hypertrophy (increased mass and relative wall thickness), or remod-
eling (normal mass but increased relative wall thickness), can be
observed. In contrast, eccentric LV hypertrophy is usually present in
patients with depressed EFs. Because of the high prevalence of
hypertension, especially in the older population, LV hypertrophy is
common, and hypertensive heart disease is the most common abnor-
mality leading to diastolic heart failure.
LV mass may be best, although laboriously, measured using
3-dimensional echocardiography.9 Nevertheless, it is possible to mea-
sure it in most patients using 2-dimensional (2D) echocardiography,
using the recently published guidelines of the American Society of
Echocardiography.10 For clinical purposes, at least LV wall thickness
should be measured in trying to arrive at conclusions on LV diastolic
function and ﬁlling pressures.
In pathologically hypertrophied myocardium, LV relaxation is
usually slowed, which reduces early diastolic ﬁlling. In the presence of
normal LA pressure, this shifts a greater proportion of LV ﬁlling to late
diastole after atrial contraction. Therefore, the presence of predomi-
nant early ﬁlling in these patients favors the presence of increased
ﬁlling pressures.
B. LA Volume
Themeasurement of LA volume is highly feasible and reliable in most
echocardiographic studies, with the most accurate measurements
obtained using the apical 4-chamber and 2-chamber views.10 This
assessment is clinically important, because there is a signiﬁcant rela-
tion between LA remodeling and echocardiographic indices of dia-
stolic function.11 However, Doppler velocities and time intervals
reﬂect ﬁlling pressures at the time of measurement, whereas LA
volume often reﬂects the cumulative effects of ﬁlling pressures over
time.
Importantly, observational studies including 6,657 patients with-
out baseline histories of atrial ﬁbrillation and signiﬁcant valvular heart
pre
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independent predictor of death, heart failure, atrial ﬁbrillation, and
ischemic stroke.12 However, one must recognize that dilated left atria
may be seen in patients with bradycardia and 4-chamber enlarge-
ment, anemia and other high-output states, atrial ﬂutter or ﬁbrillation,
and signiﬁcant mitral valve disease, in the absence of diastolic dys-
function. Likewise, it is often present in elite athletes in the absence of
cardiovascular disease (Figure 2). Therefore, it is important to con-
sider LA volume measurements in conjunction with a patient’s
clinical status, other chambers’ volumes, and Doppler parameters of
LV relaxation.
C. LA Function
The atriummodulates ventricular ﬁlling through its reservoir, conduit,
and pump functions.13 During ventricular systole and isovolumic
relaxation, when the atrioventricular (AV) valves are closed, atrial
chambers work as distensible reservoirs accommodating blood ﬂow
from the venous circulation (reservoir volume is deﬁned as LA
passive emptying volume minus the amount of blood ﬂow reversal in
the pulmonary veins with atrial contraction). The atrium is also a
pumping chamber, which contributes to maintaining adequate LV
end-diastolic volume by actively emptying at end-diastole (LA stroke
volume is deﬁned as LA volume at the onset of the electrocardio-
graphic P wave minus LA minimum volume). Finally, the atrium
behaves as a conduit that starts with AV valve opening and terminates
before atrial contraction and can be deﬁned as LV stroke volume
minus the sum of LA passive and active emptying volumes. The
reservoir, conduit, and stroke volumes of the left atrium can be
computed and expressed as percentages of LV stroke volume.13
Impaired LV relaxation is associated with a lower early diastolic
AV gradient and a reduction in LA conduit volume, while the
reservoir-pump complex is enhanced to maintain optimal LV end-
diastolic volume and normal stroke volume. With a more advanced
degree of diastolic dysfunction and reduced LA contractility, the LA
contribution to LV ﬁlling decreases.
Aside from LA stroke volume, LA systolic function can be assessed
using a combination of 2D and Doppler measurements14,15 as the
LA ejection force (preload dependent, calculated as 0.5  1.06 
mitral annular area  [peak A velocity]2) and kinetic energy (0.5 
LA volume in apical 4-chamber view
Figure 2 (Left) End-systolic (maximum) LA volume from an elite
pattern acquired by PW Doppler from the same subject. Mitral
had trivial MR, which was captured by PW Doppler. Notice the1.06 LA stroke volume [A velocity]2). In addition, recent reportshave assessed LA strain and strain rate and their clinical associations
in patients with atrial ﬁbrillation.16,17 Additional studies are needed
to better deﬁne these clinical applications.
D. Pulmonary Artery Systolic and Diastolic Pressures
Symptomatic patients with diastolic dysfunction usually have in-
creased pulmonary artery (PA) pressures. Therefore, in the absence of
pulmonary disease, increased PA pressures may be used to infer the
presence of elevated LV ﬁlling pressures. Indeed, a signiﬁcant corre-
lation was noted between PA systolic pressure and noninvasively
derived LV ﬁlling pressures.18 The peak velocity of the tricuspid
regurgitation (TR) jet by continuous-wave (CW) Doppler together
with systolic right atrial (RA) pressure (Figure 3) are used to derive PA
systolic pressure.19 In patients with severe TR and low systolic right
E
A
Mitral inflow at tips by PW Doppler
te with a volume index of 33 mL/m2. (Right) Normal mitral inflow
locity was 100 cm/s, and A velocity was 38 cm/s. This athlete
sence of a larger LA volume despite normal function.
Figure 3 Calculation of PA systolic pressure using the TR jet. In
this patient, the peak velocity was 3.6 m/s, and RA pressure
was estimated at 20 mm Hg.athle
E veventricular–RA pressure gradients, the accuracy of the PA systolic
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RA pressure.
Likewise, the end-diastolic velocity of the pulmonary regurgitation
(PR) jet (Figure 4) can be applied to derive PA diastolic pressure.19
Both signals can be enhanced, if necessary, using agitated saline or
intravenous contrast agents, with care to avoid overestimation caused
by excessive noise in the signal. The estimation of RA pressure is
needed for both calculations and can be derived using inferior vena
caval diameter and its change with respiration, as well as the ratio of
systolic to diastolic ﬂow signals in the hepatic veins.19
PA diastolic pressure by Doppler echocardiography usually corre-
lates well with invasively measured mean pulmonary wedge pressure
and may be used as its surrogate.20 The limitations to this approach
are in the lower feasibility rates of adequate PR signals (60%),
particularly in intensive care units and without intravenous contrast
agents. In addition, its accuracy depends heavily on the accurate estima-
tion of mean RA pressure, which can be challenging in some cases. The
assumption relating PA diastolic pressure to LA pressure has reason-
able accuracy in patients without moderate or severe pulmonary
hypertension. However, in patients with pulmonary vascular resis-
tance  200 dynes · s · cm5 or mean PA pressures  40 mm Hg,
PA diastolic pressure is higher (5 mm Hg) than mean wedge
pressure.21
III. MITRAL INFLOW
A. Acquisition and Feasibility
Pulsed-wave (PW) Doppler is performed in the apical 4-chamber
view to obtain mitral inﬂow velocities to assess LV ﬁlling.22 Color
ﬂow imaging can be helpful for optimal alignment of the Doppler
beam, particularly when the left ventricle is dilated. Performing CW
Doppler to assess peak E (early diastolic) and A (late diastolic)
velocities should be performed before applying the PW technique to
ensure that maximal velocities are obtained. A 1-mm to 3-mm
sample volume is then placed between the mitral leaﬂet tips during
diastole to record a crisp velocity proﬁle (Figure 2). Optimizing
spectral gain and wall ﬁlter settings is important to clearly display the
onset and cessation of LV inﬂow. Excellent-quality mitral inﬂow
waveforms can be recorded in nearly all patients. Spectral mitral
velocity recordings should be initially obtained at sweep speeds of 25
to 50 mm/s for the evaluation of respiratory variation of ﬂow
Figure 4 Calculation of PA diastolic pressure using the PR jet
(left) and hepatic venous by PW Doppler (right). In this patient,
the PR end-diastolic velocity was 2 m/s (arrow), and RA
pressure was estimated at 15 to 20 mm Hg (see Quiñones et
al19 for details on estimating mean RA pressure).velocities, as seen in patients with pulmonary or pericardial disease(see the following). If variation is not present, the sweep speed is
increased to 100 mm/s, at end-expiration, and averaged over 3
consecutive cardiac cycles.
B. Measurements
Primary measurements of mitral inﬂow include the peak early ﬁlling
(E-wave) and late diastolic ﬁlling (A-wave) velocities, the E/A ratio,
deceleration time (DT) of early ﬁlling velocity, and the IVRT, derived
by placing the cursor of CW Doppler in the LV outﬂow tract to
simultaneously display the end of aortic ejection and the onset of
mitral inﬂow. Secondary measurements include mitral A-wave
duration (obtained at the level of the mitral annulus), diastolic
ﬁlling time, the A-wave velocity-time integral, and the total mitral
inﬂow velocity-time integral (and thus the atrial ﬁlling fraction)
with the sample volume at the level of the mitral annulus.22
Middiastolic ﬂow is an important signal to recognize. Low veloci-
ties can occur in normal subjects, but when increased (20 cm/s),
they often represent markedly delayed LV relaxation and elevated
ﬁlling pressures.23
C. Normal Values
Age is a primary consideration when deﬁning normal values of mitral
inﬂow velocities and time intervals. With increasing age, the mitral E
velocity and E/A ratio decrease, whereas DT and A velocity increase.
Normal values are shown in Table 1.24 A number of variables other
than LV diastolic function and ﬁlling pressures affect mitral inﬂow,
including heart rate and rhythm, PR interval, cardiac output, mitral
annular size, and LA function. Age-related changes in diastolic func-
tion parameters may represent a slowing of myocardial relaxation,
which predisposes older individuals to the development of diastolic
heart failure.
D. Inflow Patterns and Hemodynamics
Mitral inﬂow patterns are identiﬁed by the mitral E/A ratio and DT.
They include normal, impaired LV relaxation, pseudonormal LV
ﬁlling (PNF), and restrictive LV ﬁlling. The determination of PNF may
be difﬁcult by mitral inﬂow velocities alone (see the following).
Additionally, less typical patterns are sometimes observed, such as the
triphasic mitral ﬂow velocity ﬂow pattern. The most abnormal dia-
stolic physiology and LV ﬁlling pattern variants are frequently seen in
elderly patients with severe and long-standing hypertension or pa-
tients with hypertrophic cardiomyopathy.
It is well established that the mitral E-wave velocity primarily
reﬂects the LA-LV pressure gradient (Figure 5) during early diastole
and is therefore affected by preload and alterations in LV relax-
ation.25 The mitral A-wave velocity reﬂects the LA-LV pressure
gradient during late diastole, which is affected by LV compliance
and LA contractile function. E-wave DT is inﬂuenced by LV
relaxation, LV diastolic pressures following mitral valve opening,
and LV compliance (ie, the relationship between LV pressure and
volume). Alterations in LV end-systolic and/or end-diastolic vol-
umes, LV elastic recoil, and/or LV diastolic pressures directly
affect the mitral inﬂow velocities (ie, E wave) and time intervals (ie,
DT and IVRT).
E. Clinical Application to Patients With Depressed and
Normal EFs
In patients with dilated cardiomyopathies, PW Doppler mitral ﬂow
velocity variables and ﬁlling patterns correlate better with cardiac
ﬁlling pressures, functional class, and prognosis than LV EF.26-47Patients with impaired LV relaxation ﬁlling are the least symptomatic,
ed, n
112 Nagueh et al Journal of the American Society of Echocardiography
February 2009while a short IVRT, short mitral DT, and increased E/A velocity ratio
characterize advanced diastolic dysfunction, increased LA pressure,
and worse functional class. A restrictive ﬁlling pattern is associated
with a poor prognosis, especially if it persists after preload reduction.
Likewise, a pseudonormal or restrictive ﬁlling pattern associated with
acute myocardial infarction indicates an increased risk for heart
failure, unfavorable LV remodeling, and increased cardiovascular
mortality, irrespective of EF.
In patients with coronary artery disease48 or hypertrophic cardio-
myopathy,49,50 in whom LV EFs are50%, mitral variables correlate
poorly with hemodynamics. This may be related to the marked
variation in the extent of delayed LV relaxation seen in these patients,
which may produce variable transmitral pressure gradients for similar
LA pressures. A restrictive ﬁlling pattern and LA enlargement in a
patient with a normal EF are associated with a poor prognosis similar
to that of a restrictive pattern in dilated cardiomyopathy. This is most
commonly seen in restrictive cardiomyopathies, especially amyloid-
Table 1 Normal values for Doppler-derived diastolic measurem
Measurement 16-20 21
IVRT (ms) 50  9 (32-68) 67  8 (5
E/A ratio 1.88  0.45 (0.98-2.78) 1.53  0.40
DT (ms) 142  19 (104-180) 166  14 (
A duration (ms) 113  17 (79-147) 127  13 (
PV S/D ratio 0.82  0.18 (0.46-1.18) 0.98  0.32
PV Ar (cm/s) 16  10 (1-36) 21  8 (5
PV Ar duration (ms) 66  39 (1-144) 96  33 (
Septal e= (cm/s) 14.9  2.4 (10.1-19.7) 15.5  2.7
Septal e=/a= ratio 2.4* 1.6  0.5
Lateral e= (cm/s) 20.6  3.8 (13-28.2) 19.8  2.9
Lateral e=/a= ratio 3.1* 1.9  0.6
Data are expressed as mean  SD (95% confidence interval). Note tha
for subjects aged 21 to 40 years. This is because e= increases progressi
in a normal 20-year-old than in a normal 16-year-old, which results in
considered.
*Standard deviations are not included because these data were comput
Figure 5 Schematic diagram of the changes in mitral inflow in
response to the transmitral pressure gradient.osis,51,52 and in heart transplant recipients.53F. Limitations
LV ﬁlling patterns have a U-shaped relation with LV diastolic
function, with similar values seen in healthy normal subjects and
patients with cardiac disease. Although this distinction is not an
issue when reduced LV systolic function is present, the problem of
recognizing PNF and diastolic heart failure in patients with normal
EFs was the main impetus for developing the multiple ancillary
measures to assess diastolic function discussed in subsequent
sections. Other factors that make mitral variables more difﬁcult to
interpret are sinus tachycardia,54 conduction system disease, and
arrhythmias.
Sinus tachycardia and ﬁrst-degree AV block can result in partial or
complete fusion of the mitral E and A waves. If mitral ﬂow velocity at
the start of atrial contraction is20 cm/s, mitral A-wave velocity may
be increased, which reduces the E/A ratio. With partial E-wave and
A-wave fusion, mitral DT may not be measurable, although IVRT
should be unaffected. With atrial ﬂutter, LV ﬁlling is heavily inﬂu-
enced by the rapid atrial contractions, so that no E velocity, E/A ratio,
or DT is available for measurement. If 3:1 or 4:1 AV block is present,
multiple atrial ﬁlling waves are seen, with diastolic mitral regurgitation
(MR) interspersed between nonconducted atrial beats.55 In these
cases, PA pressures calculated from Doppler TR and PR velocities
may be the best indicators of increased LV ﬁlling pressures when lung
disease is absent.
Key Points
1. PW Doppler is performed in the apical 4-chamber view to obtain mitral
inﬂow velocities to assess LV ﬁlling.
2. A 1-mm to 3-mm sample volume is then placed between the mitral leaﬂet
tips during diastole to record a crisp velocity proﬁle.
3. Primary measurements include peak E and A velocities, E/A ratio, DT, and
IVRT.
4. Mitral inﬂow patterns include normal, impaired LV relaxation, PNF, and
restrictive LV ﬁlling.
5. In patients with dilated cardiomyopathies, ﬁlling patterns correlate better
with ﬁlling pressures, functional class, and prognosis than LV EF.
6. In patients with coronary artery disease and those with hypertrophic
cardiomyopathy in whom the LV EFs are50%, mitral velocities correlate
Age group (y)
41-60 >60
74  7 (60-88) 87  7 (73-101)
3-2.33) 1.28  0.25 (0.78-1.78) 0.96  0.18 (0.6-1.32)
94) 181  19 (143-219) 200  29 (142-258)
53) 133  13 (107-159) 138  19 (100-176)
4-1.62) 1.21  0.2 (0.81-1.61) 1.39  0.47 (0.45-2.33)
23  3 (17-29) 25  9 (11-39)
2) 112  15 (82-142) 113  30 (53-173)
-20.9) 12.2  2.3 (7.6-16.8) 10.4  2.1 (6.2-14.6)
.6) 1.1  0.3 (0.5-1.7) 0.85  0.2 (0.45-1.25)
5.6) 16.1  2.3 (11.5-20.7) 12.9  3.5 (5.9-19.9)
.1) 1.5  0.5 (0.5-2.5) 0.9  0.4 (0.1-1.7)
e= velocity in subjects aged 16 to 20 years, values overlap with those
ith age in children and adolescents. Therefore, the e= velocity is higher
ewhat lower average e= value when subjects aged 16 to 20 years are
ot directly provided in the original articles from which they were derived.ents
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A. Performance and Acquisition
The Valsalva maneuver is performed by forceful expiration (about 40
mm Hg) against a closed nose and mouth, producing a complex
hemodynamic process involving 4 phases.56 LV preload is reduced
during the strain phase (phase II), and changes in mitral inﬂow are
observed to distinguish normal from PNF patterns. The patient must
generate a sufﬁcient increase in intrathoracic pressure, and the sonog-
rapher needs to maintain the correct sample volume location be-
tween the mitral leaﬂet tips during the maneuver. A decrease of 20
cm/s in mitral peak E velocity is usually considered an adequate effort
in patients without restrictive ﬁlling.
B. Clinical Application
A pseudonormal mitral inﬂow pattern is caused by a mild to moder-
ate increase in LA pressure in the setting of delayed myocardial
relaxation. Because the Valsalva maneuver decreases preload during
the strain phase, pseudonormal mitral inﬂow changes to a pattern of
impaired relaxation. Hence, mitral E velocity decreases with a pro-
longation of DT, whereas the A velocity is unchanged or increases,
such that the E/A ratio decreases.57 On the other hand, with a normal
mitral inﬂow velocity pattern, both E and A velocities decrease
proportionately, with an unchanged E/A ratio. When computing the
E/A ratio with Valsalva, the absolute A velocity (peak A minus the
height of E at the onset of A) should be used. In cardiac patients, a
decrease of50% in the E/A ratio is highly speciﬁc for increased LV
ﬁlling pressures,57 but a smaller magnitude of change does not always
indicate normal diastolic function. Furthermore, the lack of reversibil-
ity with Valsalva is imperfect as an indicator that the diastolic ﬁlling
pattern is irreversible.
C. Limitations
One major limitation of the Valsalva maneuver is that not everyone
is able to perform this maneuver adequately, and it is not standard-
ized. Its clinical value in distinguishing normal from pseudonormal
mitral inﬂow has diminished since the introduction of tissue Doppler
recordings of the mitral annulus to assess the status of LV relaxation
and estimate ﬁlling pressures more quantitatively and easily. In a busy
Figure 6 Recording of mitral inflow at the level of the annulus (l
LVEDP. Notice the markedly increased pulmonary venous A
comparison with mitral A (late diastolic) velocity. Mitral A duratclinical laboratory, the Valsalva maneuver can be reserved for patientsin whom diastolic function assessment is not clear after mitral inﬂow
and annular velocity measurements.
Key Points
1. The Valsalva maneuver is performed by forceful expiration (about 40 mm
Hg) against a closed nose and mouth, producing a complex hemodynamic
process involving 4 phases.
2. In cardiac patients, a decrease of 50% in the E/A ratio is highly speciﬁc
for increased LV ﬁlling pressures,57 but a smaller magnitude of change does
not always indicate normal diastolic function.
V. PULMONARY VENOUS FLOW
A. Acquisition and Feasibility
PW Doppler of pulmonary venous ﬂow is performed in the apical
4-chamber view and aids in the assessment of LV diastolic function.22
Color ﬂow imaging is useful for the proper location of the sample
volume in the right upper pulmonary vein. In most patients, the best
Doppler recordings are obtained by angulating the transducer supe-
riorly such that the aortic valve is seen. A 2-mm to 3-mm sample
volume is placed 0.5 cm into the pulmonary vein for optimal
recording of the spectral waveforms. Wall ﬁlter settings must be low
enough to display the onset and cessation of the atrial reversal (Ar)
velocity waveform. Pulmonary venous ﬂow can be obtained in
80% of ambulatory patients,58 though the feasibility is much lower
in the intensive care unit setting. The major technical problem is LA
wall motion artifacts, caused by atrial contraction, which interferes
with the accurate display of Ar velocity. It is recommended that
spectral recordings be obtained at a sweep speed of 50 to 100 mm/s
at end-expiration and that measurements include the average of 3
consecutive cardiac cycles.
B. Measurements
Measurements of pulmonary venous waveforms include peak sys-
tolic (S) velocity, peak anterograde diastolic (D) velocity, the S/D
ratio, systolic ﬁlling fraction (Stime-velocity integral/[Stime-velocity integral 
Dtime-velocity integral]), and the peak Ar velocity in late diastole.
Other measurements are the duration of the Ar velocity, the time
difference between it and mitral A-wave duration (Ar  A); and D
nd pulmonary venous flow (right) from a patient with increased
ocity at 50 cm/s and its prolonged duration at 200 ms in
s best recorded at the level of the annulus.22eft) a
r velvelocity DT. There are two systolic velocities (S1 and S2), mostly
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related to atrial relaxation. S2 should be used to compute the ratio of
peak systolic to peak diastolic velocity.
C. Hemodynamic Determinants
S1 velocity is primarily inﬂuenced by changes in LA pressure and
LA contraction and relaxation,59,60 whereas S2 is related to stroke
volume and pulse-wave propagation in the PA tree.59,60 D veloc-
ity is inﬂuenced by changes in LV ﬁlling and compliance and
changes in parallel with mitral E velocity.61 Pulmonary venous Ar
velocity and duration are inﬂuenced by LV late diastolic pressures,
atrial preload, and LA contractility.62 A decrease in LA compli-
ance and an increase in LA pressure decrease the S velocity and
increase the D velocity, resulting in an S/D ratio  1, a systolic
ﬁlling fraction  40%,63 and a shortening of the DT of D velocity,
usually 150 ms.64
With increased LVEDP, Ar velocity and duration increase (Figure 6),
as well as the time difference between Ar duration and mitral A-wave
duration.48,65,66 Atrial ﬁbrillation results in a blunted S wave and the
absence of Ar velocity.
D. Normal Values
Pulmonary venous inﬂow velocities are inﬂuenced by age (Table 1).
Normal young subjects aged 40 years usually have prominent D
velocities, reﬂecting their mitral E waves. With increasing age, the S/D
ratio increases. In normal subjects, Ar velocities can increase with age
but usually do not exceed 35 cm/s. Higher values suggest increased
LVEDP.67
E. Clinical Application to Patients With Depressed and
Normal EFs
In patients with depressed EFs, a reduced systolic fraction of antero-
grade ﬂow (40%) is related to decreased LA compliance and
increased mean LA pressure. This observation has limited accuracy in
patients with EFs 50%,48 atrial ﬁbrillation,68 mitral valve disease,69
and hypertrophic cardiomyopathy.50
On the other hand, the Ar  A duration difference is particularly
useful because it is the only age-independent indication of LV A-wave
pressure increase67 and can separate patients with abnormal LV
relaxation into those with normal ﬁlling pressures and those with
elevated LVEDPs but normal mean LA pressures. This isolated
increase in LVEDP is the ﬁrst hemodynamic abnormality seen with
diastolic dysfunction. Other Doppler echocardiographic variables,
such as maximal LA size, mitral DT, and pseudonormal ﬁlling, all
indicate an increase in mean LA pressure and a more advanced stage
of diastolic dysfunction. In addition, the Ar  A duration difference
remains accurate in patients with normal EFs,48 mitral valve dis-
ease,70 and hypertrophic cardiomyopathy.50 In summary, an Ar A
velocity duration  30 ms indicates an elevated LVEDP. Unlike
mitral inﬂow velocities, few studies have shown the prognostic role of
pulmonary venous ﬂow.71-73
F. Limitations
One of the important limitations in interpreting pulmonary venous
ﬂow is the difﬁculty in obtaining high-quality recordings suitable for
measurements. This is especially true for Ar velocity, for which atrial
contraction can create low-velocity wall motion artifacts that obscure
the pulmonary ﬂow velocity signal. Sinus tachycardia and ﬁrst-degree
AV block often result in the start of atrial contraction occurring before
diastolic mitral and pulmonary venous ﬂow velocity has declined to
the zero baseline. This increases the width of the mitral A-wavevelocity and decreases that of the reversal in the pulmonary vein,
making the Ar-A relationship difﬁcult to interpret for assessing LV
A-wave pressure increase. With atrial ﬁbrillation, the loss of atrial
contraction and relaxation reduces pulmonary venous systolic ﬂow
regardless of ﬁlling pressures. With a ﬁrst-degree AV block of 300
ms, ﬂow into the left atrium with its relaxation (S1) cannot be
separated from later systolic ﬂow (S2), or can even occur in diastole.
Key Points
1. PW Doppler of pulmonary venous ﬂow is performed in the apical 4-cham-
ber view and aids in the assessment of LV diastolic function.
2. A 2-mm to 3-mm sample volume is placed 0.5 cm into the pulmonary
vein for optimal recording of the spectral waveforms.
3. Measurements include peak S and D velocities, the S/D ratio, systolic ﬁlling
fraction, and peak Ar velocity in late diastole. Another measurement is the
time difference between Ar duration and mitral A-wave duration (ArA).
4. With increased LVEDP, Ar velocity and duration increase, as well as the
Ar  A duration.
5. In patients with depressed EFs, reduced systolic ﬁlling fractions (40%) are
related to decreased LA compliance and increased mean LA pressure.
VI. COLOR M-MODE FLOW PROPAGATION VELOCITY
A. Acquisition, Feasibility, and Measurement
The most widely used approach for measuring mitral-to-apical ﬂow
propagation is the slope method.74,75 The slope method (Figure 7)
appears to have the least variability.76 Acquisition is performed in the
apical 4-chamber view, using color ﬂow imaging with a narrow color
sector, and gain is adjusted to avoid noise. The M-mode scan line is
placed through the center of the LV inﬂow blood column from the
mitral valve to the apex. Then the color ﬂow baseline is shifted to
lower the Nyquist limit so that the central highest velocity jet is blue.
Flow propagation velocity (Vp) is measured as the slope of the ﬁrst
aliasing velocity during early ﬁlling, measured from the mitral valve
plane to 4 cm distally into the LV cavity.75 Alternatively, the slope of
the transition from no color to color is measured.74 Vp  50 cm/s is
considered normal.75,77 It is also possible to estimate the mitral-to-
apical pressure gradient noninvasively by color M-mode Doppler by
taking into account inertial forces,78,79 but this approach is compli-
cated and not yet feasible for routine clinical application.
B. Hemodynamic Determinants
Similar to transmitral ﬁlling, normal LV intracavitary ﬁlling is domi-
Flow Propagation Velocity: Vp
Figure 7 Color M-mode Vp from a patient with depressed EF
and impaired LV relaxation. The slope (arrow) was 39 cm/s.nated by an early wave and an atrial-induced ﬁlling wave. Most of the
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changes markedly during delayed relaxation with myocardial isch-
emia and LV failure. In the normal ventricle, the early ﬁlling wave
propagates rapidly toward the apex and is driven by a pressure
gradient between the LV base and the apex.80 This gradient repre-
sents a suction force and has been attributed to LV restoring forces
and LV relaxation. During heart failure and during myocardial isch-
emia, there is slowing of mitral-to-apical ﬂow propagation, consistent
with a reduction of apical suction.74,81,82 However, evaluation and
interpretation of intraventricular ﬁlling in clinical practice is compli-
cated by the multitude of variables that determine intraventricular
ﬂow. Not only driving pressure, inertial forces, and viscous friction but
geometry, systolic function, and contractile dyssynchrony play major
roles.83,84 Furthermore, ﬂow occurs in multiple and rapidly changing
directions, forming complex vortex patterns. The slow mitral-to-
apical ﬂow propagation in a failing ventricle is in part attributed to ring
vortices that move slowly toward the apex.79 In these settings, the
relationship between mitral-to-apical Vp and the intraventricular
pressure gradient is more complicated. The complexity of intraven-
tricular ﬂow and the limitations of current imaging techniques make
it difﬁcult to relate intraventricular ﬂow patterns to LV myocardial
function in a quantitative manner.
C. Clinical Application
There is a well-deﬁned intraventricular ﬂow disturbance that has
proved to be a semiquantitative marker of LV diastolic dysfunction,
that is, the slowing of mitral-to-apical ﬂow propagation measured by
color M-mode Doppler. In addition, it is possible to use Vp in
conjunction with mitral E to predict LV ﬁlling pressures.
Studies in patients have shown that the ratio of peak E velocity to
Vp is directly proportional to LA pressure, and therefore, E/Vp can be
used to predict LV ﬁlling pressures by itself75 and in combination with
IVRT.85 In most patients with depressed EFs, multiple echocardio-
graphic signs of impaired LV diastolic function are present, and Vp is
often redundant as a means to identify diastolic dysfunction. How-
ever, in this population, should other Doppler indices appear incon-
clusive, Vp can provide useful information for the prediction of LV
ﬁlling pressures, and E/Vp  2.5 predicts PCWP  15 mm Hg with
reasonable accuracy.86
D. Limitations
Caution should be exercised when using the E/Vp ratio for the
prediction of LV ﬁlling pressures in patients with normal EFs.86 In
particular, patients with normal LV volumes and EFs but abnormal
ﬁlling pressures can have a misleadingly normal Vp.83,84,86 In addi-
tion, there are reports showing a positive inﬂuence of preload on Vp
in patients with normal EFs87 as well as those with depressed EFs.88
Key Points
1. Acquisition is performed in the apical 4-chamber view, using color ﬂow
imaging.
2. The M-mode scan line is placed through the center of the LV inﬂow blood
column from the mitral valve to the apex, with baseline shift to lower the
Nyquist limit so that the central highest velocity jet is blue.
3. Vp is measured as the slope of the ﬁrst aliasing velocity during early ﬁlling,
measured from the mitral valve plane to 4 cm distally into the LV cavity, or
the slope of the transition from no color to color.
4. Vp  50 cm/s is considered normal.
5. In most patients with depressed EFs, Vp is reduced, and should other
Doppler indices appear inconclusive, an E/Vp ratio  2.5 predicts PCWP
 15 mm Hg with reasonable accuracy.6. Patients with normal LV volumes and EFs but elevated ﬁlling pressures can
have misleadingly normal Vp.
VII. TISSUE DOPPLER ANNULAR EARLY AND LATE
DIASTOLIC VELOCITIES
A. Acquisition and Feasibility
PW tissue Doppler imaging (DTI) is performed in the apical views to
acquire mitral annular velocities.89 Although annular velocities can
also be obtained by color-coded DTI, this method is not recom-
mended, because the validation studies were performed using PW
Doppler. The sample volume should be positioned at or 1 cm within
the septal and lateral insertion sites of the mitral leaﬂets and adjusted
as necessary (usually 5-10 mm) to cover the longitudinal excursion of
the mitral annulus in both systole and diastole. Attention should be
directed to Doppler spectral gain settings, because annular velocities
have high signal amplitude. Most current ultrasound systems have
tissue Doppler presets for the proper velocity scale and Doppler wall
ﬁlter settings to display the annular velocities. In general, the velocity
scale should be set at about 20 cm/s above and below the zero-
velocity baseline, though lower settings may be needed when there is
severe LV dysfunction and annular velocities are markedly reduced
(scale set to 10-15 cm/s). Minimal angulation (20°) should be
present between the ultrasound beam and the plane of cardiac
motion. DTI waveforms can be obtained in nearly all patients
(95%), regardless of 2D image quality. It is recommended that
spectral recordings be obtained at a sweep speed of 50 to 100 mm/s
at end-expiration and that measurements should reﬂect the average
of 3 consecutive cardiac cycles.
B. Measurements
Primary measurements include the systolic (S), early diastolic, and late
diastolic velocities.90 The early diastolic annular velocity has been
expressed as Ea, Em, E=, or e=, and the late diastolic velocity as Aa,
Am, A=, or a=. The writing group favors the use of e= and a=, because
Ea is commonly used to refer to arterial elastance. The measurement
of e= acceleration and DT intervals, as well as acceleration and
deceleration rates, does not appear to contain incremental informa-
tion to peak velocity alone91 and need not be performed routinely.
On the other hand, the time interval between the QRS complex and
e= onset is prolonged with impaired LV relaxation and can provide
incremental information in special patient populations (see the fol-
lowing). For the assessment of global LV diastolic function, it is
recommended to acquire and measure tissue Doppler signals at least
at the septal and lateral sides of the mitral annulus and their average,
given the inﬂuence of regional function on these velocities and time
intervals.86,92
Once mitral ﬂow, annular velocities, and time intervals are ac-
quired, it is possible to compute additional time intervals and ratios.
The ratios include annular e=/a= and the mitral inﬂow E velocity to
tissue Doppler e= (E/e=) ratio.90 The latter ratio plays an important
role in the estimation of LV ﬁlling pressures. For time intervals, the
time interval between the QRS complex and the onset of mitral E
velocity is subtracted from the time interval between the QRS
complex and e= onset to derive (TE-e=), which can provide incremental
information to E/e= in special populations, as outlined in the following
discussion. Technically, it is important to match the RR intervals for
measuring both time intervals (time to E and time to e=) and to
optimize gain and ﬁlter settings, because higher gain and ﬁlters can
preclude the correct identiﬁcation of the onset of e= velocity.
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The hemodynamic determinants of e= velocity include LV relaxation
(Figure 8), preload, systolic function, and LV minimal pressure. A
signiﬁcant association between e= and LV relaxation was observed in
animal93,94 and human95-97 studies. For preload, LV ﬁlling pressures
have a minimal effect on e= in the presence of impaired LV relax-
ation.87,93,94 On the other hand, with normal or enhanced LV
relaxation, preload increases e=.93,94,98,99 Therefore, in patients with
cardiac disease, e= velocity can be used to correct for the effect of LV
relaxation on mitral E velocity, and the E/e= ratio can be applied for
the prediction of LV ﬁlling pressures (Figure 9). The main hemody-
namic determinants of a= include LA systolic function and LVEDP,
such that an increase in LA contractility leads to increased a= velocity,
whereas an increase in LVEDP leads to a decrease in a=.93
In the presence of impaired LV relaxation and irrespective of LA
14cm/s
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e’
a’
Figure 8 Tissue Doppler (TD) recording from the lateral mitral an
a 58-year-old patient with hypertension, LV hypertrophy, and i
Mitral Inflow a
Septal E/e’ = 80/4 = 20
E
A
e’
Figure 9 Mitral inflow (top), septal (bottom left), and lateral (botto
failure and normal EF. The E/e= ratio was markedly increased,pressure, the e= velocity is reduced and delayed, such that it occurs atthe LA-LV pressure crossover point.94,100 On the other hand, mitral
E velocity occurs earlier with PNF or restrictive LV ﬁlling. Accord-
ingly, the time interval between the onset of E and e= is prolonged
with diastolic dysfunction. Animal94,100 and human100 studies have
shown that (TE-e=) is strongly dependent on the time constant of LV
relaxation and LV minimal pressure.100
D. Normal Values
Normal values (Table 1) of DTI-derived velocities are inﬂuenced by
age, similar to other indices of LV diastolic function. With age, e=
velocity decreases, whereas a= velocity and the E/e= ratio increase.101
E. Clinical Application
Mitral annular velocities can be used to draw inferences about LV
relaxation and along with mitral peak E velocity (E/e= ratio) can be
Sm
8cm/s
Hypertension with LVH
58 years old
e’ a’
s from a normal subject aged 35 years (left) (e=  14 cm/s) and
ired LV relaxation (right) (e=  8 cm/s).
 Annulus TD
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e’
ght) tissue Doppler signals from a 60-year-old patient with heart
g e= from either side of the annulus.nulund
m riused to predict LV ﬁlling pressures.86,90,97,102-106 To arrive at reliable
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given patient, the presence or absence of cardiovascular disease, and
other abnormalities noted in the echocardiogram. Therefore, e= and
the E/e= ratio are important variables but should not be used as the
sole data in drawing conclusions about LV diastolic function.
It is preferable to use the average e= velocity obtained from the
septal and lateral sides of the mitral annulus for the prediction of LV
ﬁlling pressures. Because septal e= is usually lower than lateral e=
velocity, the E/e= ratio using septal signals is usually higher than the
ratio derived by lateral e=, and different cutoff values should be
applied on the basis of LV EF, as well as e= location. Although
single-site measurements are sometimes used in patients with globally
normal or abnormal LV systolic function, it is imperative to use the
average (septal and lateral) e= velocity (Figure 10) in the presence of
regional dysfunction.86 Additionally, it is useful to consider the range
in which the ratio falls. Using the septal E/e= ratio, a ratio 8 is usually
associated with normal LV ﬁlling pressures, whereas a ratio  15 is
associated with increased ﬁlling pressures.97 When the value is
between 8 and 15, other echocardiographic indices should be used.
A number of recent studies have noted that in patients with normal
EFs, lateral tissue Doppler signals (E/e= and e=/a=) have the best
correlations with LV ﬁlling pressures and invasive indices of LV
stiffness.86,106 These studies favor the use of lateral tissue Doppler
signals in this population.
TE-e= is particularly useful in situations in which the peak e= velocity
has its limitations, and the average of 4 annular sites is more accurate
than a single site measurement100 for this time interval. The clinical
settings in which it becomes advantageous to use it include subjects
with normal cardiac function100 or those with mitral valve disease69
and when the E/e= ratio is 8 to 15.107 In particular, an IVRT/TE-e=
ratio  2 has reasonable accuracy in identifying patients with in-
creased LV ﬁlling pressures.100
F. Limitations
There are both technical and clinical limitations. For technical limita-
tions, proper attention to the location of the sample size, as well as
gain, ﬁlter, and minimal angulation with annular motion, is essential
for reliable velocity measurements. With experience, these are highly
reproducible with low variability. Because time interval measure-
Figure 10 Septal (left) and lateral (right) tissue Doppler recordin
the difference between septal e= (5 cm/s) and lateral e= (10 cm/s)
in such patients to arrive at more reliable assessments of LV rments are performed from different cardiac cycles, additional vari-ability is introduced. This limits their application to selective clinical
settings in which other Doppler measurements are not reliable.
There are a number of clinical settings in which annular velocity
measurements and the E/e= ratio should not be used. In normal
subjects, e= velocity is positively related to preload,98 and the E/e=
ratio may not provide a reliable estimate of ﬁlling pressures. These
individuals can be recognized by history, normal cardiac structure and
function, and the earlier (or simultaneous) onset of annular e= in
comparison with mitral E velocity.100 Additionally, e= velocity is
usually reduced in patients with signiﬁcant annular calciﬁcation,
surgical rings, mitral stenosis, and prosthetic mitral valves. It is in-
creased in patients with moderate to severe primary MR and normal
LV relaxation due to increased ﬂow across the regurgitant valve. In
these patients, the E/e= ratio should not be used, but the IVRT/TE-e=
ratio can be applied.69
Patients with constrictive pericarditis usually have increased septal
e=, due largely to preserved LV longitudinal expansion compensating
for the limited lateral and anteroposterior diastolic excursion. Lateral
e= may be less than septal e= in this condition, and the E/e= ratio was
shown to relate inversely to LV ﬁlling pressures or annulus para-
doxus.108
Key Points
1. PW DTI is performed in the apical views to acquire mitral annular
velocities.
2. The sample volume should be positioned at or 1 cm within the septal and
lateral insertion sites of the mitral leaﬂets.
3. It is recommended that spectral recordings be obtained at a sweep speed of
50 to 100 mm/s at end-expiration and that measurements should reﬂect
the average of 3 consecutive cardiac cycles.
4. Primary measurements include the systolic and early (e=) and late (a=)
diastolic velocities.
5. For the assessment of global LV diastolic function, it is recommended to
acquire and measure tissue Doppler signals at least at the septal and lateral
sides of the mitral annulus and their average.
6. In patients with cardiac disease, e= can be used to correct for the effect of
LV relaxation on mitral E velocity, and the E/e= ratio can be applied for the
prediction of LV ﬁlling pressures.
7. The E/e= ratio is not accurate as an index of ﬁlling pressures in normal
subjects or in patients with heavy annular calciﬁcation, mitral valve disease,
om a patient with an anteroseptal myocardial infarction. Notice
imperative to use the average of septal and lateral e= velocities
tion and filling pressures.gs fr
. It isand constrictive pericarditis.
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Strain means deformation and can be calculated using different
formulas. In clinical cardiology, strain is most often expressed as a
percentage or fractional strain (Lagrangian strain). Systolic strain
represents percentage shortening when measurements are done in
the long axis and percentage radial thickening in the short axis.
Systolic strain rate represents the rate or speed of myocardial short-
ening or thickening, respectively. Myocardial strain and strain rate are
excellent parameters for the quantiﬁcation of regional contractility
and may also provide important information in the evaluation of
diastolic function.
During the heart cycle, the LV myocardium goes through a
complex 3-dimensional deformation that leads to multiple shear
strains, when one border is displaced relative to another. However,
this comprehensive assessment is not currently possible by echocar-
diography. By convention, lengthening and thickening strains are
assigned positive values and shortening and thinning strains negative
values.
Until recently, the only clinical method to measure myocardial
strain has been magnetic resonance imaging with tissue tagging, but
complexity and cost limit this methodology to research protocols.
Tissue Doppler–based myocardial strain has been introduced as a
bedside clinical method and has undergone comprehensive evalua-
tion for the assessment of regional systolic function.109,110 Strain may
also be measured by 2D speckle-tracking echocardiography, an
emerging technology that measures strain by tracking speckles in
grayscale echocardiographic images.111,112 The speckles function as
natural acoustic markers that can be tracked from frame to frame, and
velocity and strain are obtained by automated measurement of
distance between speckles. The methodology is angle independent;
therefore, measurements can be obtained simultaneously from mul-
tiple regions within an image plane. This is in contrast to tissue
Doppler–based strain, which is very sensitive to misalignment be-
tween the cardiac axis and the ultrasound beam. Problems with tissue
Doppler–based strain include signiﬁcant signal noise and signal
drifting. Speckle-tracking echocardiography is limited by relatively
lower frame rates.
A number of studies suggest that myocardial strain and strain
rate may provide unique information regarding diastolic function.
This includes the quantiﬁcation of postsystolic myocardial strain as
a measure of postejection shortening in ischemic myocardium113
and regional diastolic strain rate, which can be used to evaluate
diastolic stiffness during stunning and infarction.114,115 There is
evidence in an animal model that segmental early diastolic strain
rate correlates with the degree of interstitial ﬁbrosis.115 Similarly,
regional differences in the timing of transition from myocardial
contraction to relaxation with strain rate imaging can identify
ischemic segments.116
Few studies have shown a signiﬁcant relation between segmen-
tal117 and global118 early diastolic strain rate and the time constant
of LV relaxation. Furthermore, a recent study that combined
global myocardial strain rate during the isovolumetric relaxation
period (by speckle tracking) and transmitral ﬂow velocities showed
that the mitral E velocity/global myocardial strain rate ratio pre-
dicted LV ﬁlling pressure in patients in whom the E/e= ratio was
inconclusive and was more accurate than E/e= in patients with
normal EFs and those with regional dysfunction.118 Therefore, the
evaluation of diastolic function by deformation imaging is prom-
ising but needs more study of its incremental clinical value.
Currently, Doppler ﬂow velocity and myocardial velocity imagingare the preferred initial echocardiographic methodologies for
assessing LV diastolic function.
IX. LEFT VENTRICULAR UNTWISTING
LV twisting motion (torsion) is due to contraction of obliquely
oriented ﬁbers in the subepicardium, which course toward the apex
in a counterclockwise spiral. The moments of the subepicardial ﬁbers
dominate over the subendocardial ﬁbers, which form a spiral in
opposite direction. Therefore, when viewed from apex toward the
base, the LV apex shows systolic counterclockwise rotation and the
LV base shows a net clockwise rotation. Untwisting starts in late
systole but mostly occurs during the isovolumetric relaxation period
and is largely ﬁnished at the time of mitral valve opening.119 Diastolic
untwist represents elastic recoil due to the release of restoring forces
that have been generated during the preceding systole. The rate of
untwisting is often referred to as the recoil rate. LV twist appears to
play an important role for normal systolic function, and diastolic
untwisting contributes to LV ﬁlling through suction generation.119,120
It has been assumed that the reduction in LV untwisting with
attenuation or loss of diastolic suction contributes to diastolic dys-
function in diseased hearts.120-123 Diastolic dysfunction associated
with normal aging, however, does not appear to be due to a reduction
in diastolic untwist.124
A. Clinical Application
Because the measurement of LV twist has been possible only with
tagged magnetic resonance imaging and other complex methodologies,
there is currently limited insight into how the quantiﬁcation of LV twist,
untwist, and rotation can be applied in clinical practice.120-126With the
recent introduction of speckle-tracking echocardiography, it is feasi-
ble to quantify LV rotation, twist, untwist clinically.127,128 LV twist is
calculated as the difference between basal and apical rotation mea-
sured in LV short-axis images. To measure basal rotation, the image
plane is placed just distal to the mitral annulus and for apical rotation
just proximal to the level with luminal closure at end-systole. The
clinical value of assessing LV untwisting rate is not deﬁned. When LV
twist and untwisting rate were assessed in patients with diastolic
dysfunction or diastolic heart failure, both twist and untwisting rate
were preserved,129,130 and no signiﬁcant relation was noted with the
time constant of LV relaxation.129 On the other hand, in patients
with depressed EFs, these measurements were abnormally reduced.
In an animal model, and in both groups of heart failure, the strongest
association was observed with LV end-systolic volume and twist,129
suggesting that LV untwisting rate best reﬂects the link between
systolic compression and early diastolic recoil.
In conclusion, measurements of LV twist and untwisting rate,
although not currently recommended for routine clinical use and
although additional studies are needed to deﬁne their potential
clinical application, may become an important element of diastolic
function evaluation in the future.
B. Limitations
The selection of image plane is a challenge, and further clinical testing
of speckle-tracking echocardiography in patients is needed to deter-
mine whether reproducible measurements can be obtained from
ventricles with different geometries. Speckle tracking can be subop-
timal at the LV base, thus introducing signiﬁcant variability in the
measurements.128
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A. Direct Estimation
1. IVRT. When myocardial relaxation is impaired, LV pressure falls
slowly during the isovolumic relaxation period, which results in a
longer time before it drops below LA pressure. Therefore, mitral valve
opening is delayed, and IVRT is prolonged. IVRT is easily measured
by Doppler echocardiography, as discussed in previous sections.
However, IVRT by itself has limited accuracy, given the confounding
inﬂuence of preload on it, which opposes the effect of impaired LV
relaxation.
It is possible to combine IVRT with noninvasive estimates of LV
end-systolic pressure and LA pressure to derive  (IVRT/[ln LV
end-systolic pressure  ln LA pressure]). This approach has been
validated131 and can be used to provide a quantitative estimate of 
in place of a qualitative assessment of LV relaxation.
2. Aortic regurgitation CW signal. The instantaneous pressure
gradient between the aorta and the left ventricle during diastole can
be calculated from the CW Doppler aortic regurgitant velocity
spectrum. Because the ﬂuctuation of aortic pressure during IVRT is
negligibly minor, and because LV minimal pressure is usually low, LV
pressure during the IVRT period may be derived from the CW
Doppler signal of the aortic regurgitation jet. The following hemody-
namic measurements can be derived from the CW signal: mean and
LVEDP gradients between the aorta and the left ventricle, dP/dtmin
(4V2  1,000/20, where V is aortic regurgitation velocity in meters
per second at 20 ms after the onset of regurgitation), and  (the time
interval between the onset of aortic regurgitation and the regurgitant
velocity corresponding to [1  1/e]1/2 of the maximal velocity). Tau
calculation was validated in an animal study,132 but clinical experi-
ence is limited to only a few patients.133
3. MR CW signal. Using the modiﬁed Bernoulli equation, the
maximal and mean pressure gradients between the left ventricle and
the left atrium can be determined by CW Doppler in patients with
MR, which correlate well with simultaneously measured pressures by
catheterization.134 The equation to derive dP/dtmin is dP/dtmin
(mmHg/s) [4(VMR2)
2 4(VMR1)
2 ] 1,000/20, whereVMR1 and
VMR2 are MR velocities (in meters per second) 20 ms apart. A
simpliﬁed approach to calculate  from the MR jet is  time interval
between the point of dP/dtmin to the point at which the MR
velocity  (1/e)1/2 of the MR velocity at the time of dP/dtmin.
Given the presence of more simple methods to assess myocardial
relaxation, both the aortic regurgitation and MR methods described
above are rarely used in clinical practice.
Aside from the above-described calculations, it is of value to
examine the morphology of the jets by CW Doppler. For MR, an
early rise followed by a steep descent after peak velocity are consis-
tent with a prominent “v”-wave pressure signal and elevatedmean LA
pressure. On the other hand, a rounded signal with slow ascent and
descent supports the presence of LV systolic dysfunction and im-
paired relaxation. For aortic regurgitation, in the absence of signiﬁcant
aortic valve disease (in patients with mild aortic regurgitation), a rapid
rate of decline of peak velocity and a short pressure half time are
usually indicative of a rapid rise in LV diastolic pressure due to
increased LV stiffness.
B. Surrogate Measurements
1. Mitral inflow velocities. When myocardial relaxation is mark-
edly delayed, there is a reduction in the E/A ratio (1) and aprolongation of DT (220 ms). In addition, in the presence of
bradycardia, a characteristic low middiastolic (after early ﬁlling) mitral
inﬂow velocity may be seen, due to a progressive fall in LV diastolic
pressure related to slow LV relaxation. However, increased ﬁlling
pressure can mask these changes in mitral velocities. Therefore, an
E/A ratio  1 and DT  240 ms have high speciﬁcity for abnormal
LV relaxation but can be seen with either normal or increased ﬁlling
pressures, depending on how delayed LV relaxation is. Because
impaired relaxation is the earliest abnormality in most cardiac dis-
eases, it is expected in most, if not all, patients with diastolic
dysfunction.
2. Tissue Doppler annular signals. Tissue Doppler e= is a more
sensitive parameter for abnormal myocardial relaxation than mitral
variables. Several studies in animals and humans demonstrated sig-
niﬁcant correlations between e= and  (see previous discussion). Most
patients with e= (lateral)  8.5 cm/s or e= (septal)  8 cm/s have
impaired myocardial relaxation. However, for the most reliable con-
clusions, it is important to determine whether e= is less than the mean
minus 2 standard deviations of the age group to which the patient
belongs (see Table 1).
In the presence of impaired myocardial relaxation, the time inter-
val TE-e= lengthens and correlates well with  and LV minimal
pressure. However, this approach has more variability than a single
velocity measurement and is needed in few select clinical scenarios
(see previous discussion).
3. Color M-Mode Vp. Normal Vp is50 cm/s and correlates with
the rate of myocardial relaxation. However, Vp can be increased in
patients with normal LV volumes and EFs, despite impaired relax-
ation. Therefore, Vp is most reliable as an index of LV relaxation in
patients with depressed EFs and dilated left ventricles. In the other
patient groups, it is preferable to use other indices.
Key Points
1. IVRT by itself has limited accuracy, given the confounding inﬂuence of
preload on it, which opposes the effect of impaired LV relaxation.
2. Most patients with e= (lateral)  8.5 cm/s or e= (septal)  8 cm/s have
impaired myocardial relaxation.
3. Vp is most reliable as an index of LV relaxation in patients with depressed
EFs and dilated left ventricles. In the other patient groups, it is preferable to
use other indices.
4. For research purposes, mitral and aortic regurgitation signals by CW
Doppler can be used to derive .
XI. ESTIMATION OF LEFT VENTRICULAR STIFFNESS
A. Direct estimation
Diastolic pressure-volume curves can be derived from simultaneous
high-ﬁdelity pressure recordings and mitral Doppler inﬂow, provided
ﬁlling rates (multiplying on a point-to-point basis the Doppler curve
by the diastolic annular mitral area) are integrated to obtain cumula-
tive ﬁlling volumes and normalized to stroke volume by 2D imag-
ing.135,136 Using this technique, the LV chamber stiffness constant
can be computed. The estimation of end-diastolic compliance (the
reciprocal of LV stiffness) from a single coordinate of pressure and
volume is also feasible at end-diastole, using echocardiography to
measure LV end-diastolic volume and to predict LVEDP, but this
method can be misleading in patients with advanced diastolic dys-
function.
m/s)
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1. DT of mitral E velocity. Patients with conditions associated
with increased LV stiffness have more rapid rates of deceleration
of early LV ﬁlling and shorter DTs.137 Theoretical analysis predicts
that with a relatively constant LA pressure during early LV ﬁlling,
DT is proportional to the inverse square root of LV stiffness.138
This assumption is supported by recent studies showing that LA
stiffness does not change during the period of deceleration of early
LV ﬁlling.139 Experimental observations and limited data in hu-
mans have conﬁrmed the theoretical predictions (stiffness [in
millimeters of mercury per milliliter], calculated as KLV  [70ms/
(DT  20ms)]2.140,141 To achieve greater accuracy, accounting
for viscoelasticity and LV relaxation is needed.142 In summary,
mitral DT is an important parameter that should be considered in
drawing conclusions about operative LV stiffness, particularly in
Figure 11 Exercise Doppler recordings from a patient with redu
relaxation pattern, with an E/e= ratio of 7, and the peak velocity o
supine bike exercise, mitral E velocity and the E/A ratio increase
pressure is increased to 58 mm Hg (TR peak velocity  3.8
Table 2 Changes in mitral and tissue Doppler septal
velocities with exercise in normal subjects (mean age, 59 
14 years)145
Variable Baseline Exercise
E (cm/s) 73  19 90  25
A (cm/s) 69  17 87  22
DT (ms) 192  40 176  42
e= (cm/s) 12  4 15  5
E/e= 6.7  2.2 6.6  2.5patients without marked slowing of LV relaxation.2. A-Wave transit time. LA contraction generates a pressure-
velocity wave that enters the left ventricle. The wave moves
through the inﬂow tract of the ventricle and reﬂects off the apex in
the direction of the aortic valve. The time taken for the pressure-
velocity wave to propagate through the ventricle, referred to as
A-wave transit time, may be measured using PW Doppler echo-
cardiography.143 This time interval relates well to late diastolic
stiffness (and LVEDP) measured by high-ﬁdelity pressure cathe-
ters.143,144 The limitations to this approach include its depen-
dence on Doppler sampling site, the stiffness of the containing
system, and LV geometry.
XII. DIASTOLIC STRESS TEST
Many patients with diastolic dysfunction have symptoms, mainly with
exertion, because of the rise in ﬁlling pressures that is needed to
maintain adequate LV ﬁlling and stroke volume. Therefore, it is useful
to evaluate LV ﬁlling pressure with exercise as well, similar to the use
of exercise to evaluate patients with coronary artery or mitral valve
disease. The E/e= ratio has been applied for that objective (Figure 11).
In subjects with normal myocardial relaxation, E and e= velocities
increase proportionally (Table 2), and the E/e= ratio remains un-
changed or is reduced.145 However, in patients with impaired myo-
cardial relaxation, the increase in e= with exercise is much less than
that of mitral E velocity, such that the E/e= ratio increases.146 In that
regard, E/e= was shown to relate signiﬁcantly to LV ﬁlling pressures
during exercise, when Doppler echocardiography was acquired si-
diastolic reserve. At baseline, mitral inflow shows an impaired
TR jet was 2.4 m/s (PA systolic pressure 23 mm Hg). During
shortening of DT. The E/e= ratio is now 11, and the PA systolic
.ced
f the
withmultaneously with cardiac catheterization.147 In addition, mitral DT
nd 3
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 50 ms in patients with a marked elevation of ﬁlling pressures.
In cardiac patients, mitral E velocity increases with exertion and
stays increased for a few minutes after the termination of exercise,
whereas e= velocity remains reduced at baseline, exercise, and recov-
ery. Therefore, E and e= velocities can be recorded after exercise, after
2D images have been obtained for wall motion analysis. Furthermore,
the delayed recording of Doppler velocities avoids the merging of E
and A velocities that occurs at faster heart rates. Exercise is usually
performed using a supine bicycle protocol, and TR signals by CW
Doppler are recorded as well to allow for the estimation of PA systolic
pressure at rest and during exercise and recovery. Diastolic stress
echocardiography has been also performed with dobutamine infu-
sion, and restrictive ﬁlling with dobutamine was shown to provide
prognostic information.148
The test is most useful in patients with unexplained exertional
dyspnea who have mild diastolic dysfunction and normal ﬁlling
pressures at rest. However, the paucity of clinical data and the
potential limitations in patients with regional LV dysfunction, mitral
valve disease, and atrial ﬁbrillation preclude recommendations for its
routine clinical use at this time.
XIII. OTHER REASONS FOR HEART FAILURE
SYMPTOMS IN PATIENTS WITH NORMAL
EJECTION FRACTIONS
A. Pericardial Diseases
It is important to consider the possibility of constrictive pericarditis
when evaluating patients with the clinical diagnosis of heart failure
with normal EFs, because it is potentially curable. Because LV ﬁlling
pressures are elevated in constrictive pericarditis, the mitral inﬂow
velocity pattern resembles that of pseudonormal or restrictive ﬁlling,
with E/A  1 and short DT, although a subset may have mitral E
velocity lower than A, especially during the inspiratory phase. In
addition, typically, patients with constrictive pericarditis have respira-
tory variation in mitral E velocity: a 25% increase with expira-
tion.149 However, up to 50% of patients with constrictive pericarditis
demonstrate 25% respiratory variation in mitral E velocity. On the
other hand, patients in respiratory distress, such as those with asthma,
sleep apnea, chronic obstructive lung disease, and obesity, may show
exaggerated respiratory variation in mitral E velocity due to increased
swings in intrathoracic pressure. Recording hepatic venous ﬂow is
Figure 12 Lateral (left) and septal (right) TD velocities from a pa
cm/s in comparison with lateral e= at 8 cm/s. 1  e=, 2  a=, aessential for the differential diagnosis and in establishing the presenceof constrictive pericarditis.150 The hepatic veins are usually dilated in
patients with pericardial constriction and show prominent diastolic
ﬂow reversal during expiration. Patients with restrictive cardiomyop-
athy exhibit diastolic ﬂow reversal during inspiration, whereas pa-
tients with pulmonary disease overﬁll the right heart chambers with
inspiration, as seen by large increases in superior vena cava and
inferior vena cava velocities. Patients with constrictive pericarditis and
atrial ﬁbrillation still have the typical 2D echocardiographic features,
and a longer period of Doppler velocity observation is needed to
detect velocity variation with respiration.151
Mitral annular velocities by tissue Doppler are important to ac-
quire and analyze. In patients with restrictive cardiomyopathy, myo-
cardial relaxation is impaired, leading to reductions in s= and e=
velocities and an increase in the TE-e= time interval.
152-154 However,
in patients with constriction, annular vertical excursion is usually
preserved (Figure 12). A septal e= velocity 7 cm/s is highly accurate
in differentiating patients with constrictive pericarditis from those
with restrictive cardiomyopathy. The limitations of e= are in patients
with signiﬁcant annular calciﬁcation and in those with coexisting
myocardial disease, when it is decreased despite the presence of
pericardial constriction. More recent reports have shown that in some
patients, e= also varies with respiration, but in an opposite direction to
that of mitral inﬂow.155 In addition, systolic strain is usually reduced
in patients with myocardial disease but tends to be preserved in
constriction (Table 3), where there are signs of ventricular interde-
with constrictive pericarditis. Notice the higher septal e= at 14
 systolic velocity.
Table 3 Differentiation of constrictive pericarditis from
restrictive cardiomyopathy
Variable Restriction Constriction
Septal motion Normal Respiratory shift
Mitral E/A ratio 1.5 1.5
Mitral DT (ms) 160 160
Mitral inflow respiratory
variation
Absent Usually present
Hepatic vein Doppler Inspiratory diastolic
flow reversal
Expiratory diastolic
flow reversal
Mitral septal annular e= Usually 7 cm/s Usually 7 cm/s
Mitral lateral annular e= Higher than
septal e=
Lower than
septal e=
Ventricular septal strain Reduced Usually normaltientpendence.
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during expiration in the hepatic veins, and normal or increased tissue
Doppler annular velocities should raise suspicion of constrictive
pericarditis in patients with heart failure and normal EFs, even when
the respiratory variation in mitral inﬂow is absent or not diagnostic.
B. Mitral Stenosis
Typically, patients with mitral stenosis have normal or reduced LV
diastolic pressures, except for the rare occurrence of coexisting
myocardial disease. The same hemodynamic ﬁndings are present in
patients with other etiologies of LV inﬂow obstruction, such as as LA
tumors, cor triatriatum, and congenital mitral valve stenosis.
The transmitral gradient is inﬂuenced by the severity of stenosis,
cardiac output, and the diastolic ﬁlling period. If atrial ﬁbrillation
occurs, LA pressure increases to maintain adequate LV ﬁlling. Al-
though the severity of valvular stenosis, patient symptoms, and
secondary pulmonary hypertension are the focus of clinical manage-
ment, a semiquantitative estimation of instantaneous LA pressure can
be provided in early and late diastole by Doppler variables. The
shorter the IVRT (auscultatory opening snap interval) and the higher
peak E-wave velocity (modiﬁed Bernoulli equation; P  4V2), the
higher the early diastolic LA pressure. LA pressure is signiﬁcantly
elevated at end-diastole if the mitral velocity remains1.5 m/s at this
point. In addition, the IVRT/(TE Te=) ratio correlates well with mean
PCWP and LA pressure (a ratio  4.2 is accurate in identifying
patients with ﬁlling pressures  15 mm Hg). However, the E/e= ratio
is not useful.69
Key point. Mitral stenosis renders the assessment of LV diastolic
function more challenging, but IVRT, TE-e=, and mitral inﬂow peak
velocity at early and late diastole can be of value in the semiquanti-
tative prediction of mean LA pressure.
C. MR
Primary MR leads to LA and LV enlargement and an increase in the
compliance of both chambers, which attenuates the increase in LA
pressure. If LA compensation is incomplete, mean LA pressure and
right-sided pressures increase, which is related not to LV dysfunction
but to the regurgitant volume entering the left atrium and pulmonary
veins. With LV diastolic dysfunction, a myocardial component of
increased ﬁlling pressures is added over time. The sequence is
opposite to that seen in primary myocardial disease such as dilated
cardiomyopathy, which leads to increased ﬁlling pressures earlier on
and later to functional MR. Therefore, in patients with secondary MR,
echocardiographic correlates of increased ﬁlling pressures reﬂect the
combination of both myocardial and valvular disorders.
Moderate and severe MR usually lead to an elevation of peak E
velocity and reductions in pulmonary venous systolic ﬂow wave and
the S/D ratio. In severe MR, systolic pulmonary venous ﬂow reversal
can be seen in late systole. Thus, MR per se can induce changes in
transmitral and pulmonary venous ﬂow patterns resembling ad-
vanced LV dysfunction, with the possible exception of the difference
in Ar  A duration.70 Aside from PW signals, the MR velocity
recording by CW Doppler can provide a highly speciﬁc, though not
sensitive, sign of increased LA pressure, as discussed previously.
The ability of tissue Doppler parameters (E/e=) to predict LV ﬁlling
pressures in the setting of moderate or severe MR depends on systolic
function.69,156,157 In patients with depressed EFs, an increased E/e=
ratio relates well to ﬁlling pressures and predicts hospitalizations and
mortality. In patients with normal EFs, these parameters do not
correlate with ﬁlling pressures. In contrast, IVRT and the ratio of IVRTto TE-e= correlate reasonably well with mean PCWP, regardless of
EF.69 In particular, an IVRT/TE-e= ratio  3 appears to readily predict
PCWP 15 mmHg in this patient subgroup.69 In patients with atrial
ﬁbrillation and MR, it is possible to use matched RR intervals to
calculate IVRT/TE-e=, which necessitates the acquisition of a large
number of cardiac cycles (20).
Key point. The time intervals Ar A, IVRT, and IVRT/TE-e= may be
applied for the prediction of LV ﬁlling pressures in patients with MR
and normal EFs, whereas the E/e= ratio is applicable only in the
presence of a depressed EF.
XIV. ESTIMATION OF LEFT VENTRICULAR FILLING
PRESSURES IN SPECIAL POPULATIONS (TABLE 4)
A. Atrial Fibrillation
The Doppler estimation of LV ﬁlling pressures in atrial ﬁbrillation is
limited by the variability in cycle length, the absence of organized
atrial activity, and the frequent occurrence of LA enlargement. In
Table 4 Assessment of LV filling pressures in special
populations
Disease
Echocardiographic measurements and cutoff
values
Atrial fibrillation68,104,159 Peak acceleration rate of mitral E velocity
(1,900 cm/s2), IVRT (65 ms), DT of
pulmonary venous diastolic velocity
(220 ms), E/Vp ratio (1.4), and
septal E/e= ratio (11)
Sinus tachycardia102,105 Mitral inflow pattern with predominant
early LV filling in patients with EFs 
50%, IVRT  70 ms is specific (79%),
systolic filling fraction  40% is
specific (88%), lateral E/e=  10 (a
ratio  12 has highest the specificity of
96%)
Hypertrophic
cardiomyopathy50
Lateral E/e= (10), Ar  A (30 ms), PA
pressure (35 mm Hg), and LA volume
(34 mL/m2)
Restrictive
cardiomyopathy51,52,160
DT (140 ms), mitral E/A (2.5), IVRT
(50 ms has high specificity), and
septal E/e= (15)
Noncardiac pulmonary
hypertension163
Lateral E/e= can be applied to determine
whether a cardiac etiology is the
underlying reason for the increased PA
pressures (cardiac etiology: E/e=  10;
noncardiac etiology: E/e=  8)
Mitral stenosis69 IVRT (60 ms has high specificity), IVRT/
TE-e= (4.2), mitral A velocity
(1.5 m/s)
MR69,70,157 Ar  A (30 ms), IVRT (60 ms has high
specificity), and IVRT/TE-e= (3) may be
applied for the prediction of LV filling
pressures in patients with MR and
normal EFs, whereas average E/e=
(15) is applicable only in the
presence of a depressed EF
A comprehensive approach is recommended in all of the above
settings, and conclusions should not be based on single measure-
ments. Specificity comments refer to predicting filling pressures  15
mm Hg.general, when LV EF is depressed, mitral DT (150 ms) has reason-
f 11.
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adverse clinical outcome.68,158 Other Doppler measurements that
can be applied include the peak acceleration rate of mitral E velocity
(1,900 cm/s2), IVRT (65 ms), DT of pulmonary venous159
diastolic velocity (220ms), the E/Vp ratio (1.4), and the E/e= ratio
(11). In one study,104 septal e=  8 cm/s had reasonable accuracy
in identifying patients with   50 ms. Likewise, an E/e= ratio  11
predicted LVEDP  15 mm Hg. The variability of mitral inﬂow
velocity with the RR cycle length should be examined, because
patients with increased ﬁlling pressures have less beat-to-beat varia-
tion.68 Thus, Doppler echocardiography is useful in the estimation of
ﬁlling pressures in patients with atrial ﬁbrillation. Measurements from
10 cardiac cycles are most accurate, though velocities and time
intervals averaged from 3 nonconsecutive beats with cycle lengths
within 10% to 20% of the average heart rate andmeasurements from
1 cardiac cycle with an RR interval corresponding to a heart rate of 70
to 80 beats/min are still useful.68
B. Sinus Tachycardia
Conventional mitral and pulmonary venous ﬂow velocity variables
are poor indicators of LV ﬁlling pressures in sinus tachycardia (100
beats/min) in patients with normal EFs. However, a ratio of Doppler
peak E-wave velocity to lateral mitral annular e= velocity (E/e=)  10
predicts a mean pulmonary wedge pressure  12 mm Hg with
sensitivity of 78% and speciﬁcity of 95%. Importantly, this relation
remained strong irrespective of mitral inﬂow pattern and LV EF, as
well as in the presence of a single velocity due to complete merging
of both mitral and annular E and A.102,105
C. Restrictive Cardiomyopathy
Regardless of whether idiopathic or inﬁltrative in nature, mitral,
pulmonary venous, and tissue Doppler variables are all good indica-
tors of the marked elevation in ﬁlling pressures in patients with
restrictive cardiomyopathy. A short (140 ms) mitral DT51,52,160
TR by CW Doppler
a’e’
TD at septal annulus
Figure 13 (Top left) Recording of TR jet by CW Doppler (pe
pulmonary hypertension. The right ventricular–RA systolic press
leaflet tips with mitral E velocity of 50 cm/s. (Bottom left) Recor
right) Lateral tissue Doppler signals with a normal e= velocity oand increases in either PW Doppler mitral E/A ratio (2.5) or E/e=ratio (15) indicate markedly elevated ﬁlling pressures. A short LV
IVRT of 50 ms also indicates high LA pressure due to an early
opening of the mitral valve.160
D. Hypertrophic Cardiomyopathy
In contrast to restrictive cardiomyopathies, the mitral variables of E/A
ratio and DT have weak to no correlations with LV ﬁlling pressures in
patients with hypertrophic cardiomyopathy.49,50 The marked vari-
ability in phenotype, muscle mass, amount of myocardial ﬁber disar-
ray, and obstructive versus nonobstructive physiology results in many
different combinations of altered relaxation and compliance and
resultant numerous variations of mitral inﬂow patterns. In one study,
the E/e= ratio (10, using lateral e=) correlated reasonably well with
LV pre-A pressure,50 whereas in another report, a wide spread was
seen in the noninvasive prediction of mean LA pressure.161 Similar to
other groups, Ar  A duration (30 ms) in this population may be
used to predict LVEDP.50 A comprehensive approach is recom-
mended when predicting LV ﬁlling pressures in patients with hyper-
trophic cardiomyopathy, with consideration of all echocardiographic
data, including PA pressures and LA volume (particularly in the
absence of signiﬁcant MR).
E. Pulmonary Hypertension
In patients with pulmonary hypertension, echocardiography plays an
essential role in the estimation of PA pressures, the assessment of
right ventricular size and function, and the identiﬁcation of the
underlying etiology, whether cardiac or not. If the etiology is related
to pulmonary parenchymal or vascular disease, LV ﬁlling pressures
are usually normal or low, and an impaired relaxation mitral ﬁlling
pattern is usually observed162 due to reduced LV ﬁlling rather than
diastolic dysfunction per se. Typically, these patients have normal
lateral annular e= velocities (Figure 13) and lateral E/e= ratios 8.163
Conversely, patients with pulmonary hypertension secondary to
diastolic dysfunction have increased E/e= ratios, because the mitral E
Mitral Inflow
E A
a’e’
TD at lateral annulus
elocity marked by yellow arrow) from a patient with primary
gradient is 60 mmHg. (Top right) Mitral inflow at the level of the
of septal tissue Doppler velocities with e= of 5.5 cm/s. (Bottom
5 cm/s.ak v
ure
dingvelocity is increased because of increased LA pressure, and lateral e=
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Study n Population Follow-up Events Diastolic measurement Results
Xie et al30 100 CHF, EF  40% 16  8 mo Death E/A, DT Death in res. at 1 y, 19% vs
5%; at 2 y, 51% vs 5%
Rihal et al31 102 DCM 36 mo Death E/A, DT EF  25%  DT  130 ms
had 35% 2-y survival, EF
 25%  DT  130 ms
had 72% 2-y survival, EF
 25% had 2-y survival
 95% regardless of DT
Giannuzzi et al33 508 EF  35% 29  11 mo Death  hospital
admission
DT Survival free of events 77%
when DT  125 ms,
survival free of events
18% when DT  125 ms;
DT was incremental to
age, functional class,
third heart sound, EF,
and LA area
Pozzoli et al40 173 CHF, EF  35% 17  9 mo Cardiac death and
urgent heart
transplantation
Mitral inflow
changes with
loading
Event rate 51% in
irreversible restrictive
pattern, 19% in reversible
restrictive, 33% in
unstable nonrestrictive,
and 6% in stable
nonrestrictive filling
Pinamonti et al41 110 DCM 41  20 mo Death  heart
transplantation
Mitral inflow
changes after 3
mo of treatment
After 1, 2, and 4 y, survival
of patients with persistent
restrictive (65%, 46%,
and 13%) was
significantly lower than
that of patients with
reversible restrictive
(100% at 1 and 2 y and
96% at 4 y), and those
with nonrestrictive (100%
at 1 and 2 y and 97% at
4 y)
Traversi et al32 98 ICM  DCM 12  7 mo Cardiac death and
heart
transplantation
Mitral inflow
changes after 6
mo of treatment
Event rate of 35% with
persistent restrictive
pattern, 5% with a
reversible restrictive
pattern, and 4% with
persistent nonrestrictive
pattern
Temporelli et al42 144 CHF  DT 
125 ms
26  7 mo Cardiac death DT changes after 6
mo of treatment
Event rate: 37% with
persistent restrictive
pattern vs 11% with
reversible restrictive;
prolongation of short DT
was the single best
predictor of survival
Hurrell et al34 367 Restrictive
filling: DT 
130 ms
2.2 y Death DT Survival 42% for sinus
rhythm and DT  130 ms
and 39% for atrial
fibrillation and DT  130
ms
Hansen et al35 311 ICM  DCM 512  314 d Death  heart
transplantation
Mitral inflow pattern 2-y survival rate of 52%
with restrictive pattern vs
80% with nonrestrictive
pattern; transmitral flow
was incremental to peak
oxygen consumption
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Study n Population Follow-up Events Diastolic measurement Results
Faris et al36 337 DCM 43  25 mo Death Mitral inflow pattern 1, 3, and 5 y survival of
patients with restrictive
filling (88%, 77%, and
61%) was significantly
lower than that of
patients with
nonrestrictive filling (96%,
92%, and 80%)
Whalley et al37 115 ICM  DCM 0.87  0.28 y Death  hospital
admission
Mitral inflow pattern Event rate of 62.9% with
restrictive filling vs 26.1%
in patients with impaired
relaxation
Bella et al39 3,008 American
Indians
3 y All-cause and
cardiac death
E/A All-cause mortality was
higher with E/A  0.6 or
E/A  1.5 (12% and
13%), as was cardiac
mortality (4.5% and
6.5%) vs 6% and 1.6%
for normal E/A ratio
Rossi et al38 106 DCM 524  138 d Death Mitral inflow pattern Survival rate was 38% with
restrictive filling vs 90%
with nonrestrictive filling,
after 600 d of follow-up
Dini et al72 145 ICM  DCM 15  8 mo Death  hospital
admission
DT  Ar  A The 24-mo cardiac event-
free survival was best
(86.3%) for DT  130 ms
 Ar  A 30 ms; it was
intermediate (37.9%) for
DT  130 ms  Ar  A
 30 ms; and worst
(22.9%) for DT  130 ms
 Ar  A  30 ms
Dini et al73 115 ICM  DCM 12 mo Cardiac death S/D peak velocity
ratio
Mortality was 23% with S/D
 1 and significantly
higher than in those with
S/D  1 (7%)
Yamamoto
et al168
96 ICM  DCM, EF
 40%
29  10 mo Cardiac death and
hospitalization
for CHF
Mitral, PW E/e=, a=
(posterior wall)
Survival at 40 mo was
	72% with a=  5 cm/s
and 	22% with a=  5
cm/s; on multiple
regression, A=  5 cm/s,
E/e=  15, and DT  140
ms were independent
predictors of events
Hillis et al170 250 Acute MI 13 mo Death DT, PW E/e=
(septal e=)
Mortality of 26% with E/e=
 15 and 5.6% with E/e=
 15; E/e=  15 was
incremental to clinical
data, EF, and DT  140
ms
Wang et al171 182 Cardiac patients
with EFs 
50%
48 mo Cardiac death Mitral, color-coded
e= (average of
septal, lateral,
anterior, and
inferior), Vp
Cardiac death rate was
32% with e=  3 cm/s
and 12% with e=  3 cm/
s; e= was incremental to
DT  140 ms and E/e= 
15
Wang et al173 252 Hypertension,
median EF 
51%
Median 19
mo
Cardiac death Mitral, color-coded
e= (average of
septal, lateral,
anterior, and
inferior), Vp
Cardiac death in 19 patients
(7.5%); on multivariate
regression, e= (3.5 cm/s)
was the most powerful
independent predictor of
events
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February 2009velocity is reduced because of myocardial disease. The use of septal e=
and the E/e= ratio is limited in patients with noncardiac etiologies of
pulmonary hypertension because septal e= is reduced because of right
ventricular contribution to septal velocity signals.163
With successful lowering of pulmonary vascular resistance, cardiac
output increases, the LV ﬁlling pattern reverts to being more normal,
and the lateral E/e= ratio increases.163 These changes may be of value
in monitoring the response to medical and surgical treatment of
pulmonary hypertension.
XV. PROGNOSIS
Diastolic dysfunction develops early in most cardiac diseases and
Table 5 Continued
Study n Population Follow-up
Dokainish
et al172
110 ICM  DCM 527  47 d
Troughton et al88 225 ICM  DCM (EF
 35%)
Median 10
mo
Okura et al175 230 Nonvalvular
atrial
fibrillation
245  200 d
Sharma et al174 125 End-stage renal
disease, EF
66  14%
1.61  0.56 y
Bruch et al176 370 CHF  MR,
in 92 ERO 
0.2 cm2
ICM  DCM, EF
50%
790  450 d
BNP, Brain natriuretic peptide; CHF, congestive heart failure; DCM,
cardiomyopathy; MI, myocardial infarction.leads to the elevation of LV ﬁlling pressures. Therefore, echocardio-graphic measurements of diastolic function provide important prog-
nostic information (Table 5).
Clinical studies have shown the association of short mitral DT with
heart failure and death and hospitalizations in patients presenting
with acute myocardial infarctions.30-46 Diastolic measurements pro-
vide incremental information to wall motion score index. A recent
meta-analysis of 12 post–acute myocardial infarction studies involv-
ing 1,286 patients conﬁrmed these previous observations.47 Similar
ﬁndings were reported in patients with ischemic or dilated cardiomy-
opathy, including those in atrial ﬁbrillation.34 Pulmonary venous
velocities71-73 and Vp88,164-166 were less frequently examined but
were still predictive of clinical events. Given the variability in measur-
ing DT, Vp, and pulmonary venous ﬂow velocity duration, recent
Events Diastolic measurement Results
rdiac death and
rehospitalization
for CHF
DT, PW E/e=
(average of septal
and lateral)
Predischarge BNP and E/e=
were incremental
predictors of events (54/
110, or 49% event rate)
ath  heart
transplantation

hospitalization
for CHF
DT, S/D, Vp, PW
E/e= (septal)
Event rate 45% with E/e= 
16 and 13% with E/e= 
16; event rate 37% with
E/Vp  2.7 and 22% with
E/Vp  2.7; event rate
44% with DT  170 ms
and 14% with DT  170
ms; event rate 45% with
S/D  1 and 10% with
S/D  1; E/e= and S/D
ratios independent
predictors of outcome
tal mortality,
cardiac
mortality,
incident CHF
Mitral DT, S/D, DT
of pulmonary D
velocity, PW E/e=
(septal)
Total mortality was higher
at 16.7% for E/e=  15,
and 4.3% for E/e=  15;
cardiac mortality of
11.1% for E/e=  15 vs
1.4% for E/e=  15; CHF
occurred more frequently
with E/e=  15 at 17.8%
vs 5.7% with E/e= ’ 15;
E/e= and age independent
predictors of mortality
tal mortality Mitral, pulmonary
veins, Vp, and PW
E/e= (average of
septal and lateral)
Total mortality was 9.6%
and was significantly
higher for E/e=  15; no
difference in mortality
between patients with
and without restrictive
inflow patterns
ath and
rehospitalization
for CHF
DT, PW E/e=
(average of septal
and lateral)
Mortality rate was higher in
patients with significant
MR vs those without
(33% vs 14%); in patients
with MR, event-free
survival rate was 31% for
E/e=  13.5 and 64% for
E/e=  13.5
d cardiomyopathy; ERO, effective regurgitant orifice; ICM, idiopathicCa
De
To
To
De
dilatestudies have examined the prognostic power of E/e= (Table 5).
Journal of the American Society of Echocardiography Nagueh et al 127
Volume 22 Number 2Several studies88,167-178 have shown that E/e= is highly predictive of
adverse events after acute myocardial infarction and in hypertensive
heart disease, severe secondary MR, end-stage renal disease, atrial
ﬁbrillation, and cardiomyopathic disorders.
The E/e= ratio is among the most reproducible echocardiographic
parameters to estimate PCWP and is the preferred prognostic param-
eter in many cardiac conditions.
XVI. RECOMMENDATIONS FOR CLINICAL
LABORATORIES
When the technical quality is adequate and the ﬁndings are not
equivocal, the report should include a conclusion on LV ﬁlling
pressures and the presence and grade of diastolic dysfunction.
A. Estimation of LV Filling Pressures in Patients With
Depressed EFs
The mitral inﬂow pattern by itself can be used to estimate ﬁlling
E/A <1 and E ≤ 50 cm/s
E/e’ (average e’) > 15
E/Vp ≥ 2.5
S/D < 1
Ar – A > 30 ms
Valsalva ∆ E/A > 0.5
PAS >35 mmHg
IVRT/TE-e’ <2
E/A ≥2, DT <150 ms
Mitral E/A
↑ LAP
Estimation of Filling Pressures in 
Patients with Depressed EF
E/e’ (average e’) < 8
E/Vp <1.4
S/D >1
Ar – A < 0 ms
Valsalva ∆ E/A < 0.5
PAS <30 mmHg
IVRT/TE-e’ >2
↑ LAP
Normal LAPNormal LAP
E/A ≥1 - < 2, or 
E/A < 1 and E > 50 cm/s
Figure 14 Diagnostic algorithm for the estimation of LV filling
pressures in patients with depressed EFs.
E/e’ < 8
(Sep, Lat, or Av.)
LA volume  ≥ 34 ml/m2
Ar – A ≥ 30 ms
Valsalva ∆ E/A > 0.5
PAS >35 mmHg
IVRT/TE-e’ <2
E/e’ 9-14
Sep. E/e’ > 15
or
Lat. E/e’ > 12
or
Av. E/e’ > 13
E/e’
↑ LAP
Estimation of Filling Pressures in 
Patients with Normal EF
LA volume < 34 ml/m2
Ar – A < 0 ms
Valsalva ∆ E/A < 0.5
PAS <30 mmHg
IVRT/TE-e’ >2
↑ LAPNormal LAPNormal LAP
Figure 15 Diagnostic algorithm for the estimation of LV filling
pressures in patients with normal EFs.pressures with reasonable accuracy in this population. Furthermore,the changes in the inﬂow pattern can be used to track ﬁlling pressures
in response to medical therapy. In patients with impaired relaxation
patterns and peak E velocities  50 cm/s, LV ﬁlling pressures are
usually normal. With restrictive ﬁlling, mean LA pressure is increased
(Figure 14). The use of additional Doppler parameters is recom-
mended in patients with E/A ratios1 to2. A change in E/A ratio
with the Valsalva maneuver of0.5, a systolic peak velocity/diastolic
peak velocity ratio in pulmonary venous ﬂow  1, Ar  A duration
 30 ms, E/Vp  2.5, E/e= (using average e=)  15, IVRT/TE-e=  2,
and PA systolic pressure  35 mm Hg (in the absence of pulmonary
disease) can be used to infer the presence of increased ﬁlling pres-
sures. Conversely, a change in E/A ratio with the Valsalva maneuver
of 0.5, a systolic peak velocity/diastolic peak velocity ratio in
pulmonary venous ﬂow  1, Ar  A duration  0 ms, E/Vp  1.4,
E/e= (using average e=) 8, IVRT/TE-e= 2, and PA systolic pressure
 30 mm Hg occur with normal ﬁlling pressures. In patients with
pseudonormal ﬁlling, it is preferable to base the conclusions on 2
Doppler ﬁndings, giving more weight to signals with higher technical
quality. Some LA dilatation commonly occurs in this population,
even when LV ﬁlling pressures are normal, and therefore should not
be used as the ﬁnal arbitrator in this setting.
B. Estimation of LV Filling Pressures in Patients With
Normal EFs
The estimation of LV ﬁlling pressures in patients with normal EFs is
more challenging than in patients with depressed EFs. In this patient
group, the E/e= ratio should be calculated. An average ratio  8
identiﬁes patients with normal LV ﬁlling pressures, whereas a ratio
13 indicates an increase in LV ﬁlling pressures.86 When the ratio is
between 9 and 13, other measurements are essential (Figure 15).
An Ar  A duration  30 ms, a change in E/A ratio with the
Valsalva maneuver of 0.5, IVRT/TE-e=  2, PA systolic pressure 
35mm Hg (in the absence of pulmonary disease), and maximal LA
volume  34 mL/m2 are all indicative of increased LV ﬁlling
pressures. The presence of2 abnormal measurements increases the
conﬁdence in the conclusions. Although E/Vp 1.9 occurs with
mean PCWP15 mm Hg, a number of patients with diastolic
dysfunction and normal EFs and LV volumes can have normal or
even increased Vp, resulting in ratios  1.9, even though ﬁlling
Septal e’ ≥ 8
Lateral e’ ≥ 10 
LA  < 34 ml/m2
Septal e’ < 8
Lateral e’ < 10 
LA ≥ 34 ml/m2
Septal e’
Lateral e’
LA volume
Grade I
Practical Approach to Grade Diastolic 
Dysfunction
Septal e’ ≥ 8
Lateral e’ ≥ 10 
LA ≥ 34 ml/m2
Grade II
Normal function, 
Athlete’s heart, or 
constriction
Normal. 
function Grade III
E/A < 0.8
DT > 200 ms 
Av. E/e’ ≤ 8
Ar-A < 0 ms
Val ∆E/A < 0.5
E/A  0.8-1.5
DT 160-200 ms 
Av. E/e’ 9-12
Ar-A ≥ 30 ms
Val ∆E/A ≥ 0.5
E/A ≥ 2
DT < 160 ms 
Av. E/e’ ≥ 13
Ar-A ≥ 30 ms
Val ∆E/A ≥ 0.5
Figure 16 Scheme for grading diastolic dysfunction. Av., Aver-
age; LA, left atrium; Val., Valsalva.pressures are increased.
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February 2009C. Grading Diastolic Dysfunction
The grading scheme is mild or grade I (impaired relaxation pattern),
moderate or grade II (PNF), and severe (restrictive ﬁlling) or grade III
(Figure 16). This scheme was an important predictor of all-cause
mortality in a large epidemiologic study.169 Importantly, even in
asymptomatic patients, grade I (see the following) diastolic dysfunc-
tion was associated with a 5-fold higher 3-year to 5-year mortality in
comparison with subjects with normal diastolic function. Assessment
should take into consideration patients’ ages and heart rates (mitral E,
E/A ratio, and annular e= decrease with increasing heart rate). Specif-
ically, in older individuals without histories of cardiovascular disease,
caution should be exercised before concluding that grade I diastolic
dysfunction is present. Because the majority of subjects aged 60
years without histories of cardiovascular disease have E/A ratios  1
and DTs  200 ms, such values in the absence of further indicators
of cardiovascular disease (eg, LV hypertrophy) can be considered
normal for age.
In patients with mild diastolic dysfunction, the mitral E/A ratio is
0.8, DT is 200 ms, IVRT is 100 ms, predominant systolic ﬂow
is seen in pulmonary venous ﬂow (SD), annular e= is8 cm/s, and
the E/e= ratio is 8 (septal and lateral). These patients have reduced
diastolic reserve that can be uncovered by stress testing. However, a
reduced mitral E/A ratio in the presence of normal annular tissue
Doppler velocities can be seen in volume-depleted normal subjects,
so an E/A ratio  0.8 should not be universally used to infer the
presence of diastolic dysfunction. In most situations, when the E/A
ratio is 0.8, mean LA pressure is not elevated, except for some
patients with severely impaired myocardial relaxation, as in long-
standing hypertension or hypertrophic cardiomyopathy.
In patients with moderate diastolic dysfunction (grade II), the
mitral E/A ratio is 0.8 to 1.5 (pseudonormal) and decreases by50%
during the Valsalva maneuver, the E/e= (average) ratio is 9 to 12, and
e= is 8 cm/s. Other supporting data include an Ar velocity  30
cm/s and an S/D ratio  1. In some patients with moderate diastolic
dysfunction, LV end-diastolic pressure is the only pressure that is
increased (ie, mean LA pressure is normal) and is recognized by Ar
A duration 30 ms. Grade II diastolic dysfunction represents im-
paired myocardial relaxation with mild to moderate elevation of LV
ﬁlling pressures.
With severe diastolic dysfunction (grade III), restrictive LV ﬁlling
occurs with an E/A ratio  2, DT  160 ms, IVRT  60 ms, systolic
ﬁlling fraction  40%, mitral A ﬂow duration shorter than Ar
duration, and average E/e= ratio 13 (or septal E/e= 15 and lateral
E/e= 12). LV ﬁlling may revert to impaired relaxation with success-
ful therapy in some patients (grade IIIa), whereas in others, LV ﬁlling
remains restrictive (grade IIIb). The later is an ominous ﬁnding and
predicts a high risk for cardiac morbidity and mortality. However,
grade IIIb dysfunction should not be determined by a single exami-
nation and requires serial studies after treatment is optimized. LA
volume is increased in grades II and III of diastolic dysfunction, but
can be within normal limits in grade I and in patients with preclinical
disease.
XVII. RECOMMENDATIONS FOR APPLICATION IN
RESEARCH STUDIES AND CLINICAL TRIALS
Myocardial relaxation, LV stiffness, and ﬁlling pressures can only be
assessed indirectly in the echocardiography laboratory, because the
prediction of hemodynamic data with echocardiography often im-plies simplifying assumptions, which may be valid in a given patient
population but are not necessarily applicable to all patients.
Doppler echocardiographic measurements of diastolic function
can show individual variability and can vary day to day in the same
patient with changes in preload, afterload, and sympathetic tone.
Cutoff values for differentiating normal from abnormal subjects
should consider the age group from which the study sample is
selected. It is also preferable to report Doppler measurements ad-
justed for sex, body weight, and blood pressure in statistical models,
when such relations are noted.
On the basis of a clearly formulated question, one should deﬁne
the needs: to examine changes in relaxation, stiffness, and/or ﬁlling
pressures. The main indicators of abnormal relaxation are IVRT and
isovolumetric or early diastolic annular motion or LV strain rate.
Indicators of reduced operating compliance are DT of mitral E
velocity, A-wave transit time, the ratio of LVEDP to LV end-diastolic
volume, and surrogates of increased LVEDP, namely, an abbreviated
mitral A-wave duration, reduced a=, and prolonged Ar duration in
pulmonary venous ﬂow. Indicators of early diastolic LV and LA
pressures are the E/e= ratio, DT of mitral E velocity in patients with
depressed EFs, and to some extent LA enlargement, which reﬂects
chronic rather than acute pressure changes. LV untwisting rate can be
useful in studying the effects of suction on LV ﬁlling and the link
between LV systolic and diastolic function. Each experimental ques-
tion should be addressed with the most suitable echocardiographic
approach that answers the question, as outlined in these recommen-
dations. In addition, care should be exercised when drawing infer-
ences about changes in LV relaxation, because these may occur
because of load changes per se rather than an intrinsic improvement
in myocardial function.
When selecting from the echocardiographic methods for investi-
gating problems related to diastolic function, it is possible to entertain
either a general simple approach with high feasibility and reproduc-
ibility or a more tailored and sophisticated one. Although the former
approach is suited for clinically oriented trials, the latter approach
may be superior for answering mechanistic questions. An example of
the former approach is the echocardiographic substudy of the Irbe-
sartan in Heart Failure With Preserved Systolic Function Study,
completed in April 2008.179 This substudy selected LA size, LV size
and function, LV mass index, and the E/e= ratio. On the other hand,
strain measurements by speckle tracking appear to have good repro-
ducibility and can be applied to study segmental deformation and to
address mechanistic issues.
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